| Market Cap | $530.7M | |
| Enterprise Value | — | |
| Revenue | — | — |
| Gross Profit | — | — |
| EBITDA | -$31.1M | — |
| Net Income | -$32.3M | — |
| Diluted EPS | -$0.39 | — |
| Free Cash Flow | -$23.9M | — |
| Ratio | 2024 | 2025 | Trend · 2y | vs own | vs sector |
|---|---|---|---|---|---|
| ▾Margins | |||||
| Operating Margin | −4168.81% | — | — | — | — |
| EBITDA Margin | −3662.93% | — | — | — | — |
| NOPAT Margin | −3293.36% | — | — | — | — |
| Net Margin | −4624.56% | — | — | — | — |
| FCF Margin | −3547.64% | — | — | — | — |
| OCF Margin | −3302.88% | — | — | — | — |
| Capex Intensity | 244.75% | — | — | — | — |
| ▸Returns on Capital · 2 ratios | |||||
| ▸Earnings quality · 1 ratios | |||||
| ▸Liquidity & coverage · 2 ratios | |||||
| ▸Leverage · 2 ratios | |||||
| ▸Working capital · 1 ratios | |||||
| ▸Per share · 6 ratios | |||||
| Line | 2024↗ | 2025↗ |
|---|---|---|
| Revenue | $248,357 | — |
| R&D Expense | $5.2M | $9.8M |
| YoY % | +88.7% | |
| SG&A Expense | $4.2M | $14.3M |
| YoY % | +242.2% | |
| Total Operating Expenses | $10.6M | $25.2M |
| YoY % | +137.7% | |
| Operating Income | -$10.4M | -$25.2M |
| Other Non-Operating Income | -$1.1M | -$2.8M |
| Impairment of Real Estate | $0 | $0 |
| Pretax Income | -$11.5M | -$28.0M |
| Income Tax | $20,965 | $17,950 |
| YoY % | -14.4% | |
| Net Income (incl. NCI) | -$11.5M | -$28.0M |
| Net Income | -$11.5M | -$28.0M |
| EPS (Basic) | -$0.19 | -$0.39 |
| EPS (Diluted) | -$0.19 | -$0.39 |
| Weighted Avg Shares (Basic) | 60.4M | 71.6M |
| YoY % | +18.6% | |
| Weighted Avg Shares (Diluted) | 60.4M | 71.6M |
| YoY % | +18.6% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
